HIV/AIDS COUNSELING AND TESTING POLICY FOR THE NATIONAL INSTITUTE ONDRUG ABUSE NIH GUIDE, Volume 24, Number 21, June 9, 1995 P.T. 34 Keywords: AIDS 0745007 Health and Safety Education National Institute on Drug Abuse Purpose Drug abuse and behaviors that transmit HIV are linked, and HIV risk reduction interventions have been demonstrated to effectively reduce these behaviors. Therefore, the National Institute on Drug Abuse (NIDA is establishing a policy intended to reduce drug abuse-related transmission of HIV infection in its study populations. The policy strongly encourages NIDA-funded researchers to make HIV risk reduction counseling and HIV testing available to research subjects at high risk for acquiring or transmitting HIV. AIDS is a major health problem among injection and other illicit drug users in the United States. In addition, the sexual partners of drug users are at high risk of being exposed to HIV. The majority of children with AIDS are offspring of mothers who injected drugs or were the sexual partners of drug users. Given the tremendous impact of the AIDS epidemic and the significant role of drug abuse in the transmission of HIV, the NIDA has developed this policy intended to help reduce HIV risk behaviors and infection in drug using populations, their sexual partners, and their children. As a public health research institute, NIDA believes that every reasonable opportunity should be taken to prevent HIV transmission by offering HIV education and counseling, including testing, to our clientele. Researchers funded by NIDA, who are conducting research in community outreach settings, clinics, hospital settings, or clinical laboratories and have ongoing contact with clients at risk for HIV infection, are strongly encouraged to provide HIV risk reduction education and counseling. HIV counseling should include offering HIV testing available on-site or by referral to other HIV testing services. Persons at risk for HIV infection include injection drug users, crack cocaine users, and sexually active drug users and their sexual partners. In general, the opportunity to offer education and counseling will occur in any clinical or laboratory study that provides diagnostic, treatment, or other health or social services to participants over a period of time. NIDA recognizes that this policy may be difficult to implement in some research settings, such as surveys and studies where investigator-subject contacts occur only once and are brief. However, researchers are strongly encouraged to make available HIV risk reduction materials and counseling to participants. For current grantees and contractors, NIDA will consider requests for administrative supplemental funding to implement this recommendation for ongoing studies. INQUIRIES Counseling materials developed by the NIDA AIDS Demonstration Research project and materials developed by the Centers for Disease Control and Prevention are available through NIDA for use as models by grantees and contractors. Public Health Service approved educational materials (manuals, brochures, and posters) may also be obtained by calling or writing the National Clearinghouse for Alcohol and Drug Information (1-800-729-6686) and the National AIDS Information Clearinghouse (1-800-458-5231). For additional information on this policy, contact Dr. Harry W. Haverkos Director, Office on AIDS National Institute on Drug Abuse 5600 Fishers Lane, Room 9A30 Rockville, MD 20857 Telephone: (301) 443-6046 Email: hhaverko.aoada.ssw.dhhs.gov .
Return to NIH Guide Main Index
Office of Extramural Research (OER) |
National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892 |
Department of Health and Human Services (HHS) |
||||||||